Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
PFHxS-Induced Hepatotoxicity via PPARα Pathway in Zebrafish
2026-07-14
This study elucidates how perfluorohexanesulfonic acid (PFHxS), a prevalent short-chain PFAS, induces hepatotoxicity in larval zebrafish through disruption of the PPARα signaling pathway. The findings clarify molecular mechanisms of PFHxS toxicity at environmentally relevant concentrations and provide a robust model for metabolic disease research and environmental toxicology.
-
JDJM Suppresses Wnt/β-Catenin Signaling in KOA Synovium: Ins
2026-07-14
This study delineates how Jiawei Duhuo Jisheng mixture (JDJM) downregulates the Wnt/β-catenin signaling pathway in synovial fibroblasts from knee osteoarthritis (KOA) models. Through both in vitro and in vivo experiments, JDJM demonstrated significant reduction in pathway mediators and inflammation, highlighting a promising mechanism for KOA intervention.
-
Tetraethylammonium Chloride: Precision K+ Channel Blockade W
2026-07-13
Tetraethylammonium chloride (TEAC) is the gold standard for dissecting potassium channel function in vascular and metabolic research. This guide delivers actionable workflows, advanced protocol parameters, and troubleshooting strategies to help researchers leverage TEAC’s dual-site blockade for maximal experimental resolution.
-
SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin
2026-07-13
This study demonstrates that SEMA3E promotes beige adipocyte differentiation and thermogenesis in mice through β-catenin signaling, identifying SEMA3E as a pivotal regulator of adipose tissue plasticity. These findings provide mechanistic insight with implications for metabolic disease research and potential therapeutic strategies targeting adipogenesis.
-
Rhodamine B in Precision Cell Imaging: Solubility and Signal
2026-07-12
Discover how Rhodamine B (Basic Violet 10) empowers advanced fluorescence microscopy and signal amplification workflows. This article uniquely explores solubility, storage, and mechanistic insights critical for reproducible and high-sensitivity cell labeling.
-
WEHI-539: Precision BCL-XL Inhibitor for Apoptosis Research
2026-07-10
WEHI-539 stands out as a highly selective BCL-XL inhibitor, empowering researchers to dissect apoptotic resistance and sensitize cancer stem cells with unmatched specificity. This guide details optimized workflows, troubleshooting strategies, and actionable insights to maximize experimental reproducibility using APExBIO's WEHI-539.
-
HyperScript™ Reverse Transcriptase: Advancing cDNA Synthesis
2026-07-09
This thought-leadership article explores the mechanistic and strategic advantages of HyperScript™ Reverse Transcriptase, focusing on its utility for cDNA synthesis in challenging translational research contexts such as hepatocellular carcinoma (HCC). By bridging insights from recent oncological studies with enzyme engineering, we offer actionable guidance for researchers aiming to push the boundaries of molecular diagnostics and biomarker discovery.
-
SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis
2026-07-09
The referenced study demonstrates that pharmacological inhibition of SMYD2 using AZ505 or LLY507 protects against cisplatin-induced renal fibrosis and inflammation in a chronic kidney disease (CKD) model. These findings position SMYD2 as a promising therapeutic target for preventing renal fibrosis and suggest a mechanistic link to Smad3 and STAT3 signaling.
-
Tacrolimus (FK506) in Advanced Cytokine Modulation Research
2026-07-08
Explore how Tacrolimus (FK506) enables precise modulation of cytokine signaling and T-cell activation beyond transplantation immunology. This article reveals new mechanistic insights and practical assay guidance for innovative immune response research.
-
Ceftazidime in the Era of Resistance: Molecular Insights & C
2026-07-08
Explore the role of Ceftazidime, a third-generation cephalosporin, in tackling Gram-negative bacterial resistance. This article uniquely connects molecular mechanisms with practical research and clinical protocol design, referencing the latest transmission dynamics evidence.
-
Metabolic Intervention Enhances Ferroptosis and Cuproptosis
2026-07-07
This study introduces a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to ferroptosis and cuproptosis by disrupting glycolysis and NAD+ metabolism. The strategy amplifies regulated cell death and anti-tumor immunity, offering a promising approach for next-generation cancer therapies.
-
Mubritinib (TAK 165): Protocol-Driven Advances in AML & PEL
2026-07-07
Mubritinib (TAK 165) redefines experimental workflows for chemotherapy-resistant AML and PEL by targeting mitochondrial complex I with nanomolar potency. Discover stepwise protocols, troubleshooting strategies, and data-driven advantages for deploying Mubritinib in advanced cancer and viral oncology research.
-
JZL184 and Endocannabinoid Modulation: Neuroprotection and B
2026-07-06
Explore how JZL184, a potent monoacylglycerol lipase inhibitor, is transforming research on endocannabinoid signaling modulation and neuroprotection. This article delivers advanced insights into mechanistic pathways and practical assay decisions, extending far beyond prevailing protocol guides.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Applied Wor
2026-07-06
Unlock high-sensitivity detection of mitochondrial health and apoptosis using the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide translates advanced immunomodulatory research into practical, optimized protocols and troubleshooting strategies for robust mitochondrial function analysis.
-
Technical Use of Angiotensin I/II (1-5) in RAS Research
2026-07-05
Angiotensin I/II (1-5) provides researchers with a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled modeling of renin-angiotensin system pathways in hypertension and renal studies. Its use is appropriate for blood pressure regulation and aldosterone release assays, but not for peptide signaling applications outside cardiovascular or renal physiology. Strict attention to solubility and storage is required to avoid confounding experimental results.